These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23644778)

  • 1. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
    Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
    Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
    Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
    Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome.
    Ballester LY; Benson DW; Wong B; Law IH; Mathews KD; Vanoye CG; George AL
    Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
    Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
    Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.
    Chan HF; Chen ML; Su JJ; Ko LC; Lin CH; Wu RM
    J Hum Genet; 2010 Mar; 55(3):186-8. PubMed ID: 20111058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
    Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
    Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype variability in patients carrying KCNJ2 mutations.
    Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
    Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired interaction between the slide helix and the C-terminus of Kir2.1: a novel mechanism of Andersen syndrome.
    Decher N; Renigunta V; Zuzarte M; Soom M; Heinemann SH; Timothy KW; Keating MT; Daut J; Sanguinetti MC; Splawski I
    Cardiovasc Res; 2007 Sep; 75(4):748-57. PubMed ID: 17568571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
    Lu CW; Lin JH; Rajawat YS; Jerng H; Rami TG; Sanchez X; DeFreitas G; Carabello B; DeMayo F; Kearney DL; Miller G; Li H; Pfaffinger PJ; Bowles NE; Khoury DS; Towbin JA
    J Med Genet; 2006 Aug; 43(8):653-9. PubMed ID: 16571646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.
    Marrus SB; Cuculich PS; Wang W; Nerbonne JM
    Channels (Austin); 2011; 5(6):500-9. PubMed ID: 22186697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.
    Davies NP; Imbrici P; Fialho D; Herd C; Bilsland LG; Weber A; Mueller R; Hilton-Jones D; Ealing J; Boothman BR; Giunti P; Parsons LM; Thomas M; Manzur AY; Jurkat-Rott K; Lehmann-Horn F; Chinnery PF; Rose M; Kullmann DM; Hanna MG
    Neurology; 2005 Oct; 65(7):1083-9. PubMed ID: 16217063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andersen cardiodysrhythmic periodic paralysis with KCNJ2 mutations: a novel mutation in the pore selectivity filter residue.
    Lim BC; Kim GB; Bae EJ; Noh CI; Hwang H; Kim KJ; Hwang YS; Ko TS; Chae JH
    J Child Neurol; 2010 Apr; 25(4):490-3. PubMed ID: 20382953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
    Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
    Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
    Vega AL; Tester DJ; Ackerman MJ; Makielski JC
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):540-7. PubMed ID: 19843922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
    Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
    J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel KCNJ2 sequence variant detected in Andersen-Tawil syndrome patients.
    Scheiper S; Hertel B; Beckmann BM; Kääb S; Thiel G; Kauferstein S
    BMC Med Genet; 2017 Oct; 18(1):113. PubMed ID: 29017447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
    Bendahhou S; Fournier E; Gallet S; Ménard D; Larroque MM; Barhanin J
    Hum Mol Genet; 2007 Apr; 16(8):900-6. PubMed ID: 17324964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.